generic semaglutide Canada approves from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Apotex Leads Race for Generic

Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, shared in a previous interview with Fox News Digital that this new class of weight-loss drugs is positioned to "approach bariatric surgery level outcomes" although it doesn't come without risks

On March 10, a comprehensive advisory was issued by the Central Drugs Standard Control Organisation (CDSCO) to all manufacturers prohibiting surrogate advertising and indirect promotion of semaglutides which might encourage off-label usage

10.1111/j.1749-6632.1991.tb16965.x Ann N Y Acad Sci

doi: 10.1016/j.taap.2009.05.004

BlasiFPageCRossoliniGPallecchiLMateraMRoglianiPet al

Consultation with a registered dietitian can help develop an appropriate nutrition plan